Nitric oxide synthase and cyclo-oxygenase pathways in the inflammatory response induced by zymosan in the rat air pouch

被引:44
|
作者
Paya, M
Pastor, PG
Coloma, J
Alcaraz, MJ
机构
[1] UNIV VALENCIA, FAC FARM, DEPT FARMACOL, E-46100 BURJASSOT, SPAIN
[2] UNIV VALENCIA, FAC FARM, DEPT BIOQUIM & BIOL MOL, E-46100 BURJASSOT, SPAIN
关键词
zymosan; rat air pouch; inducible nitric oxide synthase; N-G-nitro-L-arginine methyl ester; aminoguanidine; dexamethasone; cyclo-oxygenase-2; NS398;
D O I
10.1038/sj.bjp.0701073
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 We have studied the participation of nitric oxide (NO) in an animal model of 2 Saline or zymosan was injected into 6-day rat air pouches at different time points and measurements were made of cell migration, levels of nitrite/nitrate (NO2-/NO3-), prostaglandin E-2 (PGE(2)), leukotriene B-4 (LTB4) and secretory phospholipase A(2) (sPLA(2)) in exudates. Nitric oxide synthase (NOS) activity was determined in high speed supernatants from cells present in pouch exudates. Western blot analysis was also performed on these samples. 3 Zymosan injection induced a time-dependent increase in leukocyte infiltration, NO2-/NO3- levels and cellular NOS activity that reached a peak by 8 h. Western blot analysis showed the same time course for induction of NOS protein. Colchicine administration to rats inhibited cellular infiltration and decreased the levels of NO metabolites and cellular NOS activity zymosan-injected air pouch at 8 h. NOS activity was present in polymorphonuclear leukocytes (PMNs) and monocytes, but not in the lymphocytes present in exudates. This enzyme is calcium-independent and needs NADPH for activity. PGE(2) levels in exudates showed a time course inverse to that of NOS activity and NO metabolites, with maximum levels of PGE, observed at 4 h after zymosan injection. 4 Administration of NG-nitro-L-arginine methyl ester (L-NAME) or aminoguanidine to rats significantly reduced cellular NOS activity, NO2-/NO3- levels and chemiluminescence, whereas they were without effect on cell migration and degranulation, eicosanoid levels and sPLA(2) activity. 5 Treatment of animals with dexamethasone inhibited cellular NOS activity, NO2-/NO3- levels, chemiluminescence and the increase in the levels of PGE(2) and LTB4, with only a weak effect on elastase release. 6 Administration of the selective cyclo-oxygenase-2 (COX-2) inhibitor NS398 to rats strongly reduced PGE(2) levels in exudates without affecting NO metabolites or NOS activity at 4 h after zymosan injection. 7 Our data indicate that NOS is induced in the zymosan-stimulated rat air pouch model of inflammation. This enzyme is expressed in the cells migrating into the air pouch and caused an increased production of NO metabolites in exudates. The results also suggest the presence of an earlier phase in which eicosanoids play the main role, with participation of COX-2 activity, and a later phase mediated by NO. The endogenous release of NO does not modify prostaglandin biosynthesis in this in vivo model.
引用
收藏
页码:1445 / 1452
页数:8
相关论文
共 50 条
  • [31] Nitric oxide synthase-cyclo-oxygenase pathways in organum vasculosum laminae terminalis: Possible role in pyrogenic fever in rabbits
    Lin, JH
    Lin, MT
    BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 (01) : 179 - 185
  • [32] Cyclo-oxygenase and nitric oxide synthase inhibitors inhibit murine mammary tumor growth and metastasis by blocking tumor cell migration, invasion and angiogenesis.
    Lala, PK
    Jadeski, L
    Hum, K
    Rozic, J
    Chakraborty, C
    CLINICAL CANCER RESEARCH, 1999, 5 : 3811S - 3811S
  • [33] Possible interaction between NO synthase and cyclo-oxygenase in sustaining pulmonary vasodilatation: Isolated perfused rat and ferret lungs
    Liu, X
    Bee, D
    Emery, CJ
    Barer, GR
    JOURNAL OF PHYSIOLOGY-LONDON, 1996, 494P : P92 - P93
  • [34] An anti-inflammatory ditriazine inhibiting leukocyte functions and expression of inducible nitric oxide synthase and cyclo-oxygenase-2
    Rioja, I
    Ubeda, A
    Terencio, MC
    Guillén, I
    Riguera, R
    Quintela, JM
    Peinador, C
    González, LM
    Alcaraz, MJ
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 397 (01) : 207 - 217
  • [35] Involvement of endothelial cyclo-oxygenase metabolites in noradrenaline-induced contraction of rat coronary artery
    Wang, AM
    Nishihashi, T
    Trandafir, CC
    Murakami, S
    Ji, X
    Shimizi, Y
    Kurahashi, K
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2005, 32 (08): : 628 - 632
  • [36] In vitro investigation of the interaction between nitric oxide and cyclo-oxygenase activity in equine ventral colon smooth muscle
    van Hoogmoed, LM
    Harmon, FA
    Stanley, S
    White, J
    Snyder, J
    EQUINE VETERINARY JOURNAL, 2002, 34 (05) : 510 - 515
  • [37] Regulation of the inducible cyclo-oxygenase pathway in human cultured airway epithelial (A549) cells by nitric oxide
    Watkins, DN
    Garlepp, MJ
    Thompson, PJ
    BRITISH JOURNAL OF PHARMACOLOGY, 1997, 121 (07) : 1482 - 1488
  • [38] Intracellular degradation of insulin and crinophagy are maintained by nitric oxide and cyclo-oxygenase 2 activity in isolated pancreatic islets
    Sandberg, Monica
    Borg, L. A. Hakan
    BIOLOGY OF THE CELL, 2006, 98 (05) : 307 - 315
  • [39] Cytokine-mediated induction of nitric oxide synthase (type II NOS) and cyclo-oxygenase (COX-2) in vascular smooth muscle cells.
    Carrier, G
    Papapetropoulos, A
    Snead, C
    Catravas, J
    FASEB JOURNAL, 1996, 10 (03): : 2527 - 2527
  • [40] Safer non-steroidal anti-inflammatory drugs: are cyclo-oxygenase inhibitors or nitric oxide non-steroidal anti-inflammatory drugs the Grand Finale?
    Whittle, BJR
    DIGESTIVE AND LIVER DISEASE, 2002, 34 (06) : 393 - 395